338 related articles for article (PubMed ID: 18474231)
1. Inherited disorders of calcium homeostasis.
Ramasamy I
Clin Chim Acta; 2008 Aug; 394(1-2):22-41. PubMed ID: 18474231
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
3. Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor.
Pearce SH
Ann Med; 2002; 34(3):201-6. PubMed ID: 12173690
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations of the Ca2+-sensing receptor.
Mancilla EE; De Luca F; Baron J
Mol Genet Metab; 1998 Jul; 64(3):198-204. PubMed ID: 9719629
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
6. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
Pearce SH; Williamson C; Kifor O; Bai M; Coulthard MG; Davies M; Lewis-Barned N; McCredie D; Powell H; Kendall-Taylor P; Brown EM; Thakker RV
N Engl J Med; 1996 Oct; 335(15):1115-22. PubMed ID: 8813042
[TBL] [Abstract][Full Text] [Related]
7. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
[TBL] [Abstract][Full Text] [Related]
8. The role of the extracellular calcium-sensing receptor in health and disease.
Raue F; Haag C; Schulze E; Frank-Raue K
Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):397-405. PubMed ID: 17039419
[TBL] [Abstract][Full Text] [Related]
9. Calcium-sensing receptor and associated diseases.
Hendy GN; Guarnieri V; Canaff L
Prog Mol Biol Transl Sci; 2009; 89():31-95. PubMed ID: 20374733
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Ito H; Kinugasa E
Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
[TBL] [Abstract][Full Text] [Related]
11. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Ho C; Conner DA; Pollak MR; Ladd DJ; Kifor O; Warren HB; Brown EM; Seidman JG; Seidman CE
Nat Genet; 1995 Dec; 11(4):389-94. PubMed ID: 7493018
[TBL] [Abstract][Full Text] [Related]
12. Role of calcium-sensing receptor in mineral ion metabolism and inherited disorders of calcium-sensing.
Chattopadhyay N; Brown EM
Mol Genet Metab; 2006 Nov; 89(3):189-202. PubMed ID: 16919492
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-resistant diseases.
Liberman UA
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V105-7. PubMed ID: 18290711
[TBL] [Abstract][Full Text] [Related]
14. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
Carrillo-López N; Fernández-Martín JL; Cannata-Andía JB
Nefrologia; 2009; 29(2):103-8. PubMed ID: 19396314
[TBL] [Abstract][Full Text] [Related]
15. [Familial hypercalcemia and hypophosphatemia: importance in differential diagnosis of disorders in calcium-phosphate metabolism].
Zofková I
Vnitr Lek; 2010 May; 56(5):397-401. PubMed ID: 20578589
[TBL] [Abstract][Full Text] [Related]
16. [Calcium-sensing receptor and its related diseases].
Aida K; Tawata M; Onaya T
Nihon Rinsho; 1999 Mar; 57(3):746-55. PubMed ID: 10199162
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D resistance.
Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
Brown AJ; Slatopolsky E
Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and outcomes in chronic kidney disease.
Cheng S; Coyne D
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):77-82. PubMed ID: 17293681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
